Novartis Wants Rival's Atty Booted From MS Drug Patent Suit
Novartis Pharmaceutical Corp. continued to argue that a lawyer representing Shilpa Pharma Inc. must be disqualified because his testimony as a witness will likely be "central" to a patent dispute in...To view the full article, register now.
Already a subscriber? Click here to view full article